De Michieli, L.; Lupi, A.; Sinigiani, G.; Tietto, A.; Salvalaggio, A.; Branca, A.; Da Pozzo, S.; Rizzo, S.; Cecchin, D.; Perazzolo Marra, M.;
et al. Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going. J. Clin. Med. 2025, 14, 3481.
https://doi.org/10.3390/jcm14103481
AMA Style
De Michieli L, Lupi A, Sinigiani G, Tietto A, Salvalaggio A, Branca A, Da Pozzo S, Rizzo S, Cecchin D, Perazzolo Marra M,
et al. Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going. Journal of Clinical Medicine. 2025; 14(10):3481.
https://doi.org/10.3390/jcm14103481
Chicago/Turabian Style
De Michieli, Laura, Alessandro Lupi, Giulio Sinigiani, Angela Tietto, Alessandro Salvalaggio, Antonio Branca, Stefano Da Pozzo, Stefania Rizzo, Diego Cecchin, Martina Perazzolo Marra,
and et al. 2025. "Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going" Journal of Clinical Medicine 14, no. 10: 3481.
https://doi.org/10.3390/jcm14103481
APA Style
De Michieli, L., Lupi, A., Sinigiani, G., Tietto, A., Salvalaggio, A., Branca, A., Da Pozzo, S., Rizzo, S., Cecchin, D., Perazzolo Marra, M., Berno, T., Corrado, D., Briani, C., & Cipriani, A.
(2025). Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going. Journal of Clinical Medicine, 14(10), 3481.
https://doi.org/10.3390/jcm14103481
